Colorimetry, Acetaminophen

FDA classification

FDA Class 2 ·Colorimetry, Acetaminophen

Lapping Tool Kit

FDA classification

FDA Class 1 ·Lapping Tool Kit

Board, Lap, Wheelchair

FDA classification

FDA Class 1 ·Board, Lap, Wheelchair

Oral Lubricant

FDA classification

FDA Class 1 ·Oral Lubricant

Phosphoenol Pyruvate, Adp, Nadh, Pyruvate Kinase

FDA classification

FDA Class 1 ·Phosphoenol Pyruvate, Adp, Nadh, Pyruvate Kinase

Low-Density Lipoprotein (Ldl) Cholesterol Sub-Fraction Test

FDA classification

FDA Class 1 ·Low-Density Lipoprotein (Ldl) Cholesterol Sub-Fraction Test

Radioimmunoassay, Total Triiodothyronine

FDA classification

FDA Class 2 ·Radioimmunoassay, Total Triiodothyronine

Radioimmunoassay, Diphenylhydantoin

FDA classification

FDA Class 2 ·Radioimmunoassay, Diphenylhydantoin

Light Based Treatment For Cold Sores Herpes Simplex Virus-1

FDA classification

FDA Class 2 ·Light Based Treatment For Cold Sores Herpes Simplex Virus-1

Light Adjustable Lens (Lal) And Light Delivery Device (Ldd)

FDA classification

FDA Class 3 ·Light Adjustable Lens (Lal) And Light Delivery Device (Ldd)

Ldt, Not Under A Targeted Enforcement Discretion Policy Described In Preamble To Ldt Final Rule

FDA classification

FDA Not Classified ·Ldt, Not Under A Targeted Enforcement Discretion Policy Described In Preamble To Ldt Final Rule

Ldt, Approved By Nys Clep

FDA classification

FDA Not Classified ·Ldt, Approved By Nys Clep

Modified Version Of Another Manufacturer’S Fda-Authorized Test Within Scope Described In Preamble To Ldt Final Rule

FDA classification

FDA Not Classified ·Modified Version Of Another Manufacturer’S Fda-Authorized Test Within Scope Described In Preamble To Ldt Final Rule

Ldt, Unmet Need Within An Integrated Healthcare System

FDA classification

FDA Not Classified ·Ldt, Unmet Need Within An Integrated Healthcare System

Ivd Offered As Ldt, First Marketed Before May 6, 2024, Not Modified Beyond Scope Described In Preamble To Ldt Final Rule

FDA classification

FDA Not Classified ·Ivd Offered As Ldt, First Marketed Before May 6, 2024, Not Modified Beyond Scope Described In Preamble To Ldt Final Rule

Ivd Offered As Ldt, Not An Ldt Or Under A Targeted Enforcement Discretion Policy Described In Preamble To Ldt Final Rule

FDA classification

FDA Not Classified ·Ivd Offered As Ldt, Not An Ldt Or Under A Targeted Enforcement Discretion Policy Described In Preamble To Ldt Final Rule

Ldt, Non-Molecular Antisera For Rare Rbc Antigens When There Is No Alternative Ivd

FDA classification

FDA Not Classified ·Ldt, Non-Molecular Antisera For Rare Rbc Antigens When There Is No Alternative Ivd